ERCC1 mRNA Levels Can Predict the Response to Cisplatin-Based Concurrent Chemoradiotherapy of Locally Advanced Cervical Squamous Cell Carcinoma
Radiation Oncology - United Kingdom
doi 10.1186/1748-717x-7-221
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2012
Authors
Publisher
Springer Science and Business Media LLC